Combined oral contraceptives: risks and benefits

Area of Science:

• Reproductive Health
• Oncology
• Cardiovascular Medicine

Background:

• Combined oral contraceptives (COCs) are widely used by sexually active women, necessitating a thorough understanding of their health implications.
• COC use has significant long-term public health consequences due to widespread exposure.

Purpose of the Study:

• To evaluate the multifaceted health effects of combined oral contraceptives (COCs).
• To analyze the risk-benefit profile of COCs concerning cancer and cardiovascular disease.

Main Methods:

• Review of existing research on COC use and its association with various health outcomes.
• Analysis of cancer incidence (ovarian, endometrial, breast, cervical) and cardiovascular disease risk in relation to COC use.

Main Results:

• COCs provide significant long-term protection against ovarian and endometrial cancers.
• Increased cardiovascular disease risk is primarily associated with current COC use; effects of lower-dose formulations are unclear.
• The relationship between COC use and breast/cervical cancer risk is uncertain, though overall breast cancer risk is not influenced.

Conclusions:

• The net health effect of COCs depends on assumptions about breast cancer risk, with potential mortality benefits mainly from reduced ovarian cancer deaths.
• Individual risk-benefit assessments are crucial, and findings from developed countries may not apply to developing nations.